Annie Appleseed Project
  • Home
  • Cam Conference 2024
  • About Us
    • Board of Directors
    • Blog Post
    • Newsletters
    • Updates – Magazine Articles, Radio Shows, Etc.
    • Testimonials
  • Links
  • Cancer Clinics
  • Meeting Summaries
    • Cam Conference 2024
    • Cam Conference 2023 >
      • Recipes
    • Cam Conference 2020
    • Summaries From Meetings >
      • 2016 Conference
    • Agendas from Annie Appleseed Project Conferences >
      • 2020 Agenda
      • 2019 Agenda
      • 2018 Agenda
      • 2017 Agenda
      • 2016 Agenda
      • 2015 Agenda
      • 2014 Agenda
      • 2013 Agenda
      • 2012 Agenda
      • 2011 Agenda
      • 2010 Agenda
      • 2009 Agenda
      • 2008 Agenda
  • Info by Cancer Types
    • Living Beyond Breast Cancer conference
    • Alternative Cancer Therapies >
      • laetrile-vit-b17-amygdalin-from-apricot-kernels-induces-apoptosis-and-causes-cell-cycle-arrest-in-cancer-cells-an-updated-review
    • Handouts
  • Vlog
    • 2018 AAPR Conference
  • Exhibitors
  • Contact Us
  • Donate
  • Giving Tuesday

HELEN SCHIFF LETTER TO THE NEW YORK TIMES

Letter to the New York Times

To the editor:

I was pleased that the September 8, 2000 issue of The New York Times reported on the results of a Dutch study printed in The Lancet which showed that more women on tamoxifen developed a deadlier form of uterine cancer than women with uterine cancer not on tamoxifen.

However, Denise Grady, the author of the article, is wrong in reporting that the risk of uterine cancer for women over 60 taking tamoxifen is only doubled from 1 in a thousand to 2 in a thousand. A risk-benefit assessment for women taking tamoxifen for breast cancer prevention printed in the Nov. 3, 1999 issue of the Journal of the National Cancer Institute reports that women over 50 quadrupled their risk of getting uterine cancer. In fact, the number of uterine cancers caused by tamoxifen in women over 50 is actually equal to the number of breast cancers that tamoxifen prevents.

In The Breast Cancer Prevention Trial, tamoxifen appeared to prevent the least aggressive kind of breast cancer. Is tamoxifen preventing the most curable type of breast cancer, but causing a more lethal type of uterine cancer?

For almost all women who already have breast cancer the benefits of tamoxifen far outweigh the risks. However, many breast cancer survivors, including myself, believe that clinical trials using toxic drugs in healthy women should show that there is a real survival benefit, not just a reduction in incidence of breast cancer. Otherwise, we run the risk of substituting one disease for another.

Sincerely,

Helen Schiff
New York, New York

Annie Appleseed Project
​

Picture
Annie Appleseed Project - Sign Up Today!

* required

*





*



Email & Social Media Marketing by VerticalResponse
WHO WE ARE   I   PRIVACY POLICY   I   ADVERTISING POLICY   I   ARCHIVES   I   IN HONOR/MEMORY OF

​Remember: We are NOT Doctors and have NO medical training. DISCLAIMER: The information provided is for educational purposes only. It is not meant to diagnose or treat any health condition and is not a replacement for treatment by a healthcare provider. This article or site may contain copyrighted material, the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of health, political, human rights, economic, democratic, and social justice issues, etc. We believe this constitutes a “fair use” of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed an interest in receiving the included information for research and educational purposes. For more information go to: Cornell University Law School.
​© Annie Appleseed Project. All rights reserved.
  • Home
  • Cam Conference 2024
  • About Us
    • Board of Directors
    • Blog Post
    • Newsletters
    • Updates – Magazine Articles, Radio Shows, Etc.
    • Testimonials
  • Links
  • Cancer Clinics
  • Meeting Summaries
    • Cam Conference 2024
    • Cam Conference 2023 >
      • Recipes
    • Cam Conference 2020
    • Summaries From Meetings >
      • 2016 Conference
    • Agendas from Annie Appleseed Project Conferences >
      • 2020 Agenda
      • 2019 Agenda
      • 2018 Agenda
      • 2017 Agenda
      • 2016 Agenda
      • 2015 Agenda
      • 2014 Agenda
      • 2013 Agenda
      • 2012 Agenda
      • 2011 Agenda
      • 2010 Agenda
      • 2009 Agenda
      • 2008 Agenda
  • Info by Cancer Types
    • Living Beyond Breast Cancer conference
    • Alternative Cancer Therapies >
      • laetrile-vit-b17-amygdalin-from-apricot-kernels-induces-apoptosis-and-causes-cell-cycle-arrest-in-cancer-cells-an-updated-review
    • Handouts
  • Vlog
    • 2018 AAPR Conference
  • Exhibitors
  • Contact Us
  • Donate
  • Giving Tuesday